[
1. Zabielska-Koczywas K,Wojtalewicz A,Lechowski R: Current knowledge on feline injection-site sarcoma treatment. Acta Vet. Scand. 2017, 59: 47, doi:10.1186/s13028-017-0315-y.10.1186/s13028-017-0315-y551336828716129
]Search in Google Scholar
[
2. Martano M,Morello E,Buracco P: Feline injection-site sarcoma: Past, present and future perspectives. Vet. J. 2011, 188: 136-141, doi:https://doi.org/10.1016/j.tvjl.2010.04.025.10.1016/j.tvjl.2010.04.02520510635
]Search in Google Scholar
[
3. Hendrick M,Brooks J: Postvaccinal sarcomas in the cat: Histology and immunohistochemistry. Vet. Pathol. 1994, 31: 126-129.10.1177/0300985894031001218140720
]Search in Google Scholar
[
4. Esplin D,Jaffe M,M cGill L: Metastasizing liposarcoma associated with a vaccination site in a cat. Feline practice 1996:20-23.
]Search in Google Scholar
[
5. Chang HW,Ho SY,Lo HF,Tu YC,Jeng CR,Liu CH,Wang FI,Pang VF: Vaccine-associated rhabdomyosarcoma with spinal epidural invasion and pulmonary metastasis in a cat. Vet. Pathol. 2006, 43: 55-58, doi:10.1354/vp.43-1-55.10.1354/vp.43-1-5516407487
]Search in Google Scholar
[
6. Hendrick MJ. Mesen chymal tumors of the skin and soft tissues. In Tumors in domestic animals, John Wiley & Sons, Inc.: 2016; 10.1002/9781119181200.ch5pp. 142-175.10.1002/9781119181200.ch5
]Search in Google Scholar
[
7. Kass PH,Barnes WG, Jr.,Spangler WL,Chomel BB,Culbertson MR: Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J. Am. Vet. Med. Assoc. 1993, 203: 396-405.
]Search in Google Scholar
[
8. Kass PH,Spangler W L,Hendrick MJ,McGill LD,Esplin DG,Lester S,Slater M,Meyer EK,Boucher F,Peters EM: Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J. Am. Vet. Med. Assoc. 2003, 223: 1283-1292.10.2460/javma.2003.223.128314621215
]Search in Google Scholar
[
9. Esplin D,Bigelow M, McGill L,Wilson S: Fibrosarcoma at the site of a lufenuron injection in a cat. Vet. Cancer Soc. Newsletter 1999, 23: 8-9.
]Search in Google Scholar
[
10. Buracco P,Martano M,Morello E,Ratto A: Vaccine-associated-like fibrosarcoma at the site of a deep nonabsorbable suture in a cat. Vet. J. 2002, 163: 105-107, doi:10.1053/tvjl.2001.0617.10.1053/tvjl.2001.061711749145
]Search in Google Scholar
[
11. Daly MK,Saba CF,C rochik SS,Howerth EW,Kosarek CE,Cornell KK,Roberts RE,Northrup NC: Fibrosarcoma adjacent to the site of microchip implantation in a cat. J. Feline Med. Surg. 2008, 10: 202-205, doi:https://doi.org/10.1016/j.jfms.2007.10.011.10.1016/j.jfms.2007.10.01118313963
]Search in Google Scholar
[
12. McEntee MC,Page R L: Feline vaccine-associated sarcomas. J. Vet. Intern. Med. 2001, 15: 176-182.10.1111/j.1939-1676.2001.tb02308.x
]Search in Google Scholar
[
13. Wilcock B,Wilcock A,Bottoms K: Feline postvaccinal sarcoma: 20 years later. The Can. Vet. J. 2012, 53: 430-434.
]Search in Google Scholar
[
14. Woodward KN: Origi ns of injection-site sarcomas in cats: The possible role of chronic inflammation—a review. ISRN Vet. Sci. 2011, 2011: 210982, doi:10.5402/2011/210982.10.5402/2011/210982365883823738095
]Search in Google Scholar
[
15. Sorensen KC,Kitche ll BE,Schaeffer DJ,Mardis PE: Expression of matrix metalloproteinases in feline vaccine site-associated sarcomas. Am. J. Vet. Res. 2004, 65: 373-379.10.2460/ajvr.2004.65.373
]Search in Google Scholar
[
16. Malhotra B,Schuetz e SM: Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: A review of clinical trial results. Curr. Opin. Oncol. 2012, 24: 419-424, doi:10.1097/CCO.0b013e328353d78d.10.1097/CCO.0b013e328353d78d
]Search in Google Scholar
[
17. Jacobs TM,Poehlman n CE,Kiupel M: Injection-site sarcoma in a dog: Clinical and pathological findings. Case Rep. Vet. Med. 2017, 2017: 4, doi:10.1155/2017/6952634.10.1155/2017/6952634
]Search in Google Scholar
[
18. Katayama R,Huelsme yer MK,Marr AK,Kurzman ID,Thamm DH,Vail DM: Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma. Cancer Chemother Pharmacol 2004, 54: 25-33, doi:10.1007/s00280-004-0780-7.10.1007/s00280-004-0780-7
]Search in Google Scholar
[
19. Lawrence J,Saba C, Gogal R,Lamberth O,Vandenplas ML,Hurley DJ,Dubreuil P,Hermine O,Dobbin K,Turek M: Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells*. Vet. Comp. Oncol. 2012, 10: 143-154, doi:10.1111/j.1476-5829.2011.00291.x.10.1111/j.1476-5829.2011.00291.x
]Search in Google Scholar
[
20. Kilvaer TK,Valkov A,Sorbye SW,Donnem T,Smeland E,Bremnes RM,Busund LT: Platelet-derived growth factors in non-gist soft-tissue sarcomas identify a subgroup of patients with wide resection margins and poor disease-specific survival. Sarcoma 2010, 2010: 751304, doi:10.1155/2010/751304.10.1155/2010/751304
]Search in Google Scholar
[
21. Hynes RO: Integrin s: Bidirectional, allosteric signaling machines. Cell 2002, 110: 673-687.10.1016/S0092-8674(02)00971-6
]Search in Google Scholar
[
22. Takada Y,Ye X,Simo n S: The integrins. Genome Biol. 2007, 8: 215, doi:10.1186/gb-2007-8-5-215.10.1186/gb-2007-8-5-215192913617543136
]Search in Google Scholar
[
23. Barczyk M,Carraced o S,Gullberg D: Integrins. Cell Tissue Res. 2010, 339: 269-280, doi:10.1007/s00441-009-0834-6.10.1007/s00441-009-0834-6278486619693543
]Search in Google Scholar
[
24. Silletti S,Kessler T,Goldberg J,Boger DL,Cheresh DA: Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc. Natl. Acad. Sci. U. S. A. 2001, 98: 119-124, doi:10.1073/pnas.011343298.10.1073/pnas.011343298
]Search in Google Scholar
[
25. Dennis MM,McSporra n KD,Bacon NJ,Schulman FY,Foster RA,Powers BE: Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Vet. Pathol. 2011, 48: 73-84, doi:10.1177/0300985810388820.10.1177/0300985810388820
]Search in Google Scholar
[
26. Meuten DJ. Appendi x: Diagnostic schemes and algorithms. In Tumors in domestic animals, John Wiley & Sons, Inc.: 2016; 10.1002/9781119181200.apppp. 942-978.10.1002/9781119181200.app
]Search in Google Scholar
[
27. Meuten DJ,Moore FM, George JW: Mitotic count and the field of view area: Time to standardize. Vet. Pathol. 2016, 53: 7-9, doi:10.1177/0300985815593349.10.1177/0300985815593349
]Search in Google Scholar
[
28. Jones ML,Bancroft JD,Gamble M: Connective tissues and stains. Theory and practice of histological techniques 2008, 6: 135-160.10.1016/B978-0-443-10279-0.50017-8
]Search in Google Scholar
[
29. Mowry RW: Alcian b lue techniques for the histochemical study of acid carbohydrates. J Histochem Cytochem 1956, 4: 403-407.
]Search in Google Scholar
[
30. Mowry RW: The special value of methods that color both acidic and vicinal hydroxyl groups in the histochemical study of mucins. With revised directions for the colloidal iron stain, the use of alcian blue g8x and their combinations with the periodic acid-schiff reaction*. Ann. N. Y. Acad. Sci. 1963, 106: 402-423, doi:10.1111/j.1749-6632.1963.tb16654.x.10.1111/j.1749-6632.1963.tb16654.x
]Search in Google Scholar
[
31. Ahmed I,Sozmen M: Expression of pdgf-a, pdgfra, integrin subunit alpha v and selectin e is increased in canine cutaneous fibrosarcomas. Biotech. & histochem.: 2020, 1-9, doi:10.1 080/10520295.2020.1832256.
]Search in Google Scholar
[
32. Esplin D,Campbell R: Widespread metastasis of a fibrosarcoma associated with a vaccination site in a cat. Feline practice 1995, 23:13-16.
]Search in Google Scholar
[
33. Hendrick MJ,Shofer FS,Goldschmidt MH,Haviland JC,Schelling SH,Engler SJ,Gliatto JM: Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J. Am. Vet. Med. Assoc. 1994, 205: 1425-1429.
]Search in Google Scholar
[
34. Aberdein D,Munday JS,Dyer CB,Knight CG,French AF,Gibson IR: Comparison of the histology and immunohistochemistry of vaccination-site and non-vaccination-site sarcomas from cats in new zealand. N. Z. Vet. J. 2007, 55: 203-207, doi:10.1080/00480169.2007.36769.10.1080/00480169.2007.36769
]Search in Google Scholar
[
35. Couto SS,Griffey SM,Duarte PC,Madewell BR: Feline vaccine-associated fibrosarcoma: Morphologic distinctions. Vet. Pathol. 2002, 39: 33-41, doi:10.1354/vp.39-1-33.10.1354/vp.39-1-33
]Search in Google Scholar
[
36. Hendrick MJ,Goldschmidt MH,Shofer FS,Wang Y-Y,Somlyo AP: Postvaccinal sarcomas in the cat: Epidemiology and electron probe microanalytical identification of aluminum. Cancer Res. 1992, 52: 5391-5394.
]Search in Google Scholar
[
37. Doddy FD,Glickman LT,Glickman NW,Janovitz EB: Feline fibrosarcomas at vaccination sites and non-vaccination sites. J. Comp. Pathol. 1996, 114: 165-174, doi:https://doi.org/10.1016/S0021-9975(96)80005-3.10.1016/S0021-9975(96)80005-3
]Search in Google Scholar
[
38. Diep AN,Fleis RI: Pathology in practice. Widespread, metastatic liposarcoma and moderate, acute, diffuse centrilobular hepatic necrosis. J Am Vet Med Assoc 2012, 240: 391-393, doi:10.2460/javma.240.4.391.10.2460/javma.240.4.39122309010
]Search in Google Scholar
[
39. Ahmed I, Sozmen M: Proliferating cell nuclear antigen expression in canine and feline spontaneous and injection-site fibrosarcomas. Pak. Vet. J. 2020, 40: 531-533.10.29261/pakvetj/2020.019
]Search in Google Scholar
[
40. Hendrick MJ,Goldschmidt MH: Do injection site reactions induce fibrosarcomas in cats? J. Am. Vet. Med. Assoc. 1991, 199: 968.
]Search in Google Scholar
[
41. Macy DW,Hendrick MJ: The potential role of inflammation in the development of postvaccinal sarcomas in cats. Vet. Clin. North Am. Small Anim. Pract. 1996, 26: 103-109, doi:https://doi.org/10.1016/S0195-5616(96)50009-4.10.1016/S0195-5616(96)50009-4
]Search in Google Scholar
[
42. Srivastav A,Kass PH,McGill LD,Kent MS,Farver TB: Methodologic approaches to histologically distinguishing vaccine versus nonvaccine-associated sarcomas using validated time and location vaccination histories in cats. ISRN Pathol. 2011, 2011: 6, doi:10.5402/2011/375143.10.5402/2011/375143
]Search in Google Scholar
[
43. Porcellato I,Menchetti L,Brachelente C,Sforna M,Reginato A,Lepri E,Mechelli L: Feline injection-site sarcoma:Matrix remodeling and prognosis. Vet. Pathol. 2017, 54: 204-211, doi:10.1177/0300985816677148.10.1177/030098581667714828005492
]Search in Google Scholar
[
44. Madewell BR,Griffey SM,McEntee MC,Leppert VJ,Munn RJ: Feline vaccine-associated fibrosarcoma: An ultrastructural study of 20 tumors (1996–1999). Vet. Pathol. 2001, 38: 196-202, doi:10.1354/vp.38-2-196.10.1354/vp.38-2-19611280376
]Search in Google Scholar
[
45. Cessna MH,Zhou H,Perkins SL,Tripp SR,Layfield L,Daines C,Coffin CM: Are myogenin and myod1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am. J. Surg. Pathol. 2001, 25: 1150-1157.10.1097/00000478-200109000-0000511688574
]Search in Google Scholar
[
46. Hendrick MJ: Feline vaccine-associated sarcomas: Current studies on pathogenesis. J. Am. Vet. Med. Assoc. 1998, 213: 1425-1426.
]Search in Google Scholar
[
47. Teyssonneau D,Italiano A: Olaratumab for soft tissue sarcoma. Expert Opin. Biol. Ther. 2017, 17: 1019-1025, doi:10.1080/14712598.2017.1339031.10.1080/14712598.2017.133903128691538
]Search in Google Scholar
[
48. Figarella-Branger D,Vagner-Capodano AM,Bouillot P,Graziani N,Gambarelli D,Devictor B,Zattara-Cannoni H,Bianco N,Grisoli F,Pellissier JF: Platelet-derived growth factor (pdgf) and receptor (pdgfr) expression in human meningiomas: Correlations with clinicopathological features and cytogenetic analysis. Neuropathol. Appl. Neurobiol. 1994, 20: 439-447, doi:10.1111/j.1365-2990.1994.tb00994.x.10.1111/j.1365-2990.1994.tb00994.x7531297
]Search in Google Scholar
[
49. Majumdar K,Radotra BD,Vasishta RK,Pathak A: Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. Surg. Neurol. 2009, 72: 54-60, doi:10.1016/j.surneu.2008.10.001.10.1016/j.surneu.2008.10.00119559929
]Search in Google Scholar
[
50. Nejjari M,Hafdi Z,Gouysse G,Fiorentino M,Beatrix O,Dumortier J,Pourreyron C,Barozzi C,D’Errico A,Grigioni WF,Scoazec JY: Expression, regulation, and function of alpha v integrins in hepatocellular carcinoma: An in vivo and in vitro study. Hepatology 2002, 36: 418-426, doi:10.1053/jhep.2002.34611.10.1053/jhep.2002.3461112143051
]Search in Google Scholar
[
51. Felding-Habermann B,Fransvea E,O’Toole TE,Manzuk L,Faha B,Hensler M: Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis 2002, 19: 427-436.10.1023/A:1016377114119
]Search in Google Scholar
[
52. Hosotani R,Kawaguchi M,Masui T,Koshiba T,Ida J,Fujimoto K,Wada M,Doi R,Imamura M: Expression of integrin alphavbeta3 in pancreatic carcinoma: Relation to mmp-2 activation and lymph node metastasis. Pancreas 2002, 25: e30-35.10.1097/00006676-200208000-0002112142752
]Search in Google Scholar
[
53. Baum O,Hlushchuk R,Forster A,Greiner R,Clezardin P,Zhao Y,Djonov V,Gruber G: Increased invasive potential and up-regulation of mmp-2 in mda-mb-231 breast cancer cells expressing the beta3 integrin subunit. Int. J. Oncol. 2007, 30: 325-332.
]Search in Google Scholar
[
54. Wenk CH,Ponce F,Guillermet S,Tenaud C,Boturyn D,Dumy P,Watrelot-Virieux D,Carozzo C,Josserand V,Coll JL: Near-infrared optical guided surgery of highly infiltrative fibrosarcomas in cats using an anti-alphavss3 integrin molecular probe. Cancer Lett. 2013, 334: 188-195, doi:10.1016/j.canlet.2012.10.041.10.1016/j.canlet.2012.10.04123200675
]Search in Google Scholar
[
55. Bello L,Francolini M,Marthyn P,Zhang J,Carroll RS,Nikas DC,Strasser JF,Villani R,Cheresh DA,Black PM: Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 2001, 49: 380-389; discussion 390, doi:10.1097/00006123-200108000-00022.10.1097/00006123-200108000-0002211504114
]Search in Google Scholar